Original Articles
Vol. 70 No. 1 (2021)
Priority access to SARS-CoV-2/COVID-19 vaccination: an issue of values, not only of facts
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 12 April 2021
2607
Views
32
Downloads
Authors
One of the thorniest issues around the anti-SARS-CoV-2/COVID-19 vaccination campaign concerns with the access to vaccines, i.e. the order of priority to be followed, especially in the initial phase of administration, characterised by a strong imbalance between supply and demand. In Italy, access is regulated by The Strategic Plan for anti-SARSCov- 2 vaccines of December 2020, which was followed by an update document in February 2021. The aim of this paper is to analyse the two documents from an ethical point of view, particularly to examine the justifications behind the choices and their framework in the light of the egalitarian perspective of the Italian National Health Service (NHS).
Downloads
Download data is not yet available.
Citations
How to Cite
Priority access to SARS-CoV-2/COVID-19 vaccination: an issue of values, not only of facts. (2021). Medicina E Morale, 70(1), 25-34. https://doi.org/10.4081/mem.2021.927